Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.79
0.145.28%
Ult. Agg.: Nov 6, 6:40 PM
Market sentiment signals for ARS Pharmaceuticals (SPRY): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Outperform
6 analysts
Options Flow (P/C)
0.00
More calls — Bullish
Avg Consensus PT
$24
+763.3%
Highest Price Target
$40
+1338.8%
Lowest Price Target
$17
+511.5%
Short Interest
28.7%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Nov 6, 2026 | Cantor Fitzgerald | Josh Schimmer— | +619.4% | $30 → $20 | Maintained | Overweight |
| Nov 6, 2026 | Raymond James | Ryan Deschner— | +511.5% | $28 → $17 | Downgrade | Strong Buy→Outperform |
